I read a sligtly interessting article in Dagbladet today. I'm still haven't found the original source, but the the main points can also be found in this article in English, for our non-Norwegian readers (you know who you are).
Basically it is the dilemma that development countries don't have access to (the newest/ best) medicin due to high cost, while they at the same time has the most severe health problems. Professors Pogge and Hollis suggest to launch an insitution (Incentives for Global Health) that for a periode payes the pharmacuatical company a fixed prize for new drugs calculated after the impact the drug has on international health. In return, the pharmacautical company will wave their right to sell the drug at marked price and sell at cost price. The patent protection should be the same as before.
So, I was just curious: What do the readers of this blog think of this plan?
(Yeah, Wilhelm, I know that Pogge and Hollis have their PhDs in philosophy and economy, but let us see past that for now).